| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 20.699 | 48.293 | 67.110 | 130.395 | 170.598 | 120.713 | 109.072 | 123.405 | 185.690 | 121.684 |
| Total Income - EUR | 20.699 | 48.299 | 67.308 | 130.445 | 174.343 | 122.004 | 111.255 | 125.470 | 202.386 | 127.340 |
| Total Expenses - EUR | 18.237 | 27.487 | 37.139 | 79.871 | 78.939 | 42.274 | 39.689 | 49.944 | 116.046 | 68.312 |
| Gross Profit/Loss - EUR | 2.461 | 20.812 | 30.169 | 50.574 | 95.404 | 79.730 | 71.566 | 75.526 | 86.340 | 59.028 |
| Net Profit/Loss - EUR | 1.518 | 19.362 | 27.818 | 49.256 | 93.660 | 78.608 | 70.488 | 74.294 | 84.467 | 56.410 |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Check the financial reports for the company - Step-In Pharma Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 3.384 | 3.014 | 2.312 | 33.513 | 25.883 | 19.446 | 14.393 | 123.091 | 111.429 |
| Current Assets | 3.760 | 29.641 | 29.553 | 53.841 | 91.433 | 80.943 | 82.520 | 90.894 | 79.799 | 78.487 |
| Inventories | 0 | 143 | 0 | 0 | 0 | 0 | 583 | 0 | 91 | 90 |
| Receivables | 1.696 | 3.457 | 10.731 | 20.335 | 28.790 | 20.328 | 16.522 | 75.758 | 73.139 | 59.794 |
| Cash | 2.065 | 26.041 | 18.822 | 33.505 | 62.643 | 60.615 | 65.415 | 15.135 | 6.569 | 18.603 |
| Shareholders Funds | 2.047 | 21.389 | 27.871 | 49.307 | 93.711 | 78.658 | 70.537 | 74.343 | 84.516 | 140.453 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.713 | 11.636 | 6.283 | 8.403 | 32.764 | 28.181 | 31.443 | 31.283 | 119.216 | 50.819 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7490 - 7490" | |||||||||
| CAEN Financial Year |
7490
|
|||||||||
Comments - Step-In Pharma Srl